Back to all DocMorris AG press releases

DocMorris AG

  • SIX:DOCM

DocMorris receives TÜV Rheinland certification extension for refrigerated medicine deliveries

Published

Get alerts

Plain English summaries when DocMorris AG announces news.

At a glance

Company
DocMorris AG
Listings
SIX:DOCM
Announcement type
Regulatory approval
Published
Source announcement
eqs-news.com
Key figures
Measure Figure
Temperature range 2 to 8 degrees Celsius
Normal ambient temperatures 15 to 25 degrees Celsius

Figures are quoted from this announcement and selected automatically.

FAQSIR Generated from this announcement View original release below for safe harbor and regulatory notices

Announcement Summary

DocMorris’ existing ISO 9001 certification has been extended by TÜV Rheinland to cover temperature-controlled delivery of prescription, pharmacy-only, and over-the-counter medicines requiring refrigeration. The audit reviewed documentation, on-site activities, and the transport process from picking through delivery to the end customer via special carriers.

Refrigerated medicines must be stored and transported at 2 to 8 degrees Celsius, while most other medicines require 15 to 25 degrees Celsius. DocMorris stores pharmaceuticals under controlled temperatures at its fully air-conditioned logistics center and uses multi-stage monitoring. Refrigerated medicines are delivered directly in specialist refrigerated trucks with documentation. A weather-screening system can trigger additional insulation or cooling elements for shipments exposed to extreme temperatures.

Investor FAQs

DocMorris announced that TÜV Rheinland had extended its existing ISO 9001 certification to cover the temperature-controlled delivery of medicines requiring refrigeration. The extension covers the DocMorris quality management system for the procurement and shipment of prescription, pharmacy-only and over-the-counter pharmaceutical products.

Source announcement

Company
DocMorris AG
Title
DocMorris receives TÜV certification for temperature-controlled delivery of pharmaceuticals
Published
Source site
eqs-news.com

Read the source announcement on eqs-news.com

FAQSIR's summary and investor FAQs are generated by AI from the text of this announcement alone, without information from other sources.

Figures, forecasts and other claims are the announcement's, not FAQSIR's. FAQSIR does not independently verify them.

Read the original press release

Full text as published, unedited.

Loading the original release…